Please ensure Javascript is enabled for purposes of website accessibility

Teladoc Health Aims to Raise $800 Million With Convertible Notes Issue

By Eric Volkman – May 14, 2020 at 6:10PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company hasn't yet specified an interest rate for the securities.

In a business maneuver that is becoming extremely common during these chaotic economic times, Teladoc Health (TDOC -6.96%) is aiming to raise some capital through an issue of convertible securities. The provider of remote medical services, which has zoomed to greater prominence during the SARS-CoV-2 coronavirus pandemic, announced Wednesday that it intends to float an $800 million issue of convertible, unsecured senior notes.

The notes will pay interest semi-annually, on June 1 and Dec. 1 of each year beginning this December. They will mature on June 1, 2027, if not redeemed, repurchased, or converted. The company has not yet specified an interest rate for the notes.

A Teladoc member using the company's interface.

Image source: Teladoc Health.

Teladoc will hold the right to redeem them for cash starting June 5, 2024, under certain circumstances. Investors will be able to fully convert them starting on Dec. 1, 2026; before that, there will be restrictions for doing so, though those restrictions have not yet been specified.

They will be sold in a private placement. The company said it intends to grant the initial purchasers an option to purchase an additional $120 million aggregate principal amount of the same securities. 

Teladoc will use the proceeds partially to retire an issue of 3% convertible senior notes that matures in 2022. It is to offer a mix of cash and shares of its common stock in return for the notes; it did not get more specific about the amount of cash or stock that would be offered. The rest of the proceeds are to be utilized to retire debt and acquire assets should good opportunities present themselves, and as working capital.

Investors seemed displeased that the company is pulling this funding lever. They traded the stock down by 4.6% on Thursday while the broader equities market rose on the day.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Teladoc Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$26.24 (-6.96%) $-1.96

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.